Amedisys to Present at the 33rd Annual J.P. Morgan Healthcare Conference
January 08 2015 - 11:00AM
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health
and hospice care companies, today announced that Paul B. Kusserow,
President and Chief Executive Officer, Ronald A. LaBorde, Vice
Chairman, and Dale E. Redman, Interim Chief Financial Officer, will
present at the 33rd Annual J.P. Morgan Healthcare Conference in San
Francisco, CA on Wednesday, January 14, 2015.
The presentation will begin at 10:30 a.m. Pacific/1:30 p.m.
Eastern. To access a live webcast of the Amedisys presentation,
please log on through our website at
http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. (Nasdaq:AMED) is a leading health care at home
company delivering personalized home health and hospice care to
more than 360,000 patients each year. Amedisys is focused on
delivering the care that is best for our patients, whether that is
home-based recovery and rehabilitation after an operation or
injury, care focused on empowering them to manage a chronic
disease, palliative care for those with a terminal illness, or
hospice care at the end of life. The Company's state-of-the-art
advanced chronic care management programs and leading-edge
technology enables it to deliver quality care based upon the latest
evidence-based best practices. Amedisys is a recognized innovator,
being one of the first in the industry to equip its clinicians with
point-of-care laptop technology and referring physicians with an
internet portal that enables real-time coordination of patient care
seamlessly. Amedisys also has the industry's first-ever nationwide
Care Transitions program, designed to reduce unnecessary hospital
readmissions through patient and caregiver health coaching and care
coordination, which starts in the hospital and continues throughout
completion of the patient's home health plan of care. For more
information about the Company, please visit:
http://www.amedisys.com.
Our company website address is http://www.amedisys.com. We use
our website as a channel of distribution for important company
information. Important information, including press releases,
analyst presentations and financial information regarding the
Company is routinely posted on and accessible on the "Investor
Relations" subpage of our website, which is accessible by clicking
on the tab labeled "Investors" on our website home page. We will
also use our website to expedite public access to time-critical
information regarding the Company in advance of or in lieu of
distributing a press release or a filing with the Securities and
Exchange Commission ("SEC") disclosing the same information. In
addition, we make available on the Investor Relations subpage of
our website (under the link "SEC filings") free of charge our
annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, ownership reports on Forms 3, 4 and 5
and any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of
our Certificate of Incorporation and Bylaws, our Code of Ethical
Business Conduct and the charters for the Audit, Compensation and
Nominating and Governance Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
CONTACT: Amedisys, Inc.
David Castille
Managing Director, Finance
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024